Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury.
Prieto AR, Ma H, Huang R, Khan G, Schwartz KA, Hage-Korban EE, Schmaier AH, Davis JM, Hasan AA, Abela GS.
Cardiovasc Res. 2002 Mar;53(4):984-92.PMID: 11922908 [PubMed - indexed for MEDLINE]Related articlesFree article